Concept explainers
In 2008, Time magazine named as its invention of the year the development of personal genomics services by a company named 23andMe. Customers sent saliva samples to the company, which then genotyped approximately one million SNPs located across the genome, and communicated the data online to the customer along with what was claimed to be a “for education use only” assessment of potential risk for a variety of traits.
However, on November 22, 2013, the United States Food and Drug Administration (FDA) ordered 23andMe to stop marketing its personal genomics services because the accuracy of its SNP genotyping and risk predictions had not been validated as sufficiently accurate for medical use. The FDA was concerned that people might make serious medical decisions based on information from a test that was not clinically approved. Some elements of this ban were relieved in 2015 and 2017, but DNA testing services are still restrained from offering their customers all the pre-ban predictions. Defining these limits remains a contentious and unresolved issue.
a. | Can the information you would obtain from this personal genomics service tell you whether or not you have a |
b. | Can the information you would obtain from this personal genomics service inform you about your likelihood of having a disease that is a complex trait? Explain. |
c. | In December 2013, a reporter for The New York Times reported that she sent samples of her own DNA to three different companies (one of which was 23andMe), but the three companies provided very different estimates of her risk for a variety of complex traits. What were the likely causes of the differences in these estimates? |
d. | Do you think new scientific developments will help resolve these issues in the near future? |
Want to see the full answer?
Check out a sample textbook solutionChapter 22 Solutions
Genetics: From Genes to Genomes
- Answer each of the following correctly. Designer Genes Work (This is all about Applications of Recombinant DNA) 1. How does DNA Replicate? 2. What is Genetically Modified Organism (GMO)? 3. Illustrate your own Designer genes based on the following: 1. Identify a special trait. 2. Identify a source organism. 3. Identify a target orgsnism 4. Identify the modified/added trait.arrow_forwardPick one (1) of the five (5) principles developed by the Ethics Committee for the Human Genome Organization that must be considered when the global community is confronted by new technology. Why do you feel that principle is MOST important.arrow_forwardIf human genetics is leading toward preventive medicine, give the most significant expectations regarding gene therapy (please explain in detail).arrow_forward
- Topic: Recombinant pharmaceuticals (for the production of insulin, human growth hormone or blood clotting factors) Question Describe the molecular genetics process using proper scientific terminology. Describe the steps that are involved. How is it performed?arrow_forwardDescribe the methodology that you would use to determine the association between specific sequence variations or epigenetic modifications and observed diseases in humans. Given your newfound knowledge of this association how would you then design a genetic test that could be used to identify individuals within a given population who have developed the disease or at risk of developing the disease. “The disease” here refers to any heritable genetic disease..arrow_forwardFrom your knowledge about DNA microarray, answer the following: If the expression microarray experiment was done with a normal sample and a suspected sample, after reading the color pattern resulted from the experiment it was recorded that “gene A22” is expressed in the suspected sample. The gene A22 is clinically linked to colon cancer. Answer the following: What is the expected color of the spot on the microarray which represents this gene? What is your interpretation of the suspected sample; is it a cancer sample or not and explain why?arrow_forward
- 1. a) If you were at risk of a fatal disease such as Huntington’s disease and only the 95% accurate preliminary genetic test was available, would you take the test? After all, 95% of the time the test would tell you whether you would eventually get Huntington’s disease or whether you did not have to worry about getting this disease. b) The linkage distance between the DNA sequence used in the test and the actual Huntington’ disease locus was 5%. In a large sample of the Venezuelan family, what percentage of people would inherit the DNA sequence but not the Huntington’s allele (i.e. be a false positive test for Huntington’s)? What percentage of that large Venezuelan family would not inherit the DNA sequence but would inherit the Huntington’s allele (i.e., be a false negative test for Huntington’s)?arrow_forwardWhat activities does the Genetic Information Nondiscrimination Act prohibit?arrow_forwardSTR markers: are point mutations detectable by DNA sequencing are variations in the number of repeats of very short DNA motifs (2-10 nucleotides) □have high polymorphism are mutations leading to proteins or blood groups that can be differentiated by antigenic testing from a blood sample ☐have low polymorphism no correct answer are changes of a few nucleotides leading to the absence or presence of a site recognized by a restriction enzyme are variations in the number of repeats of medium-sized DNA motifs (10-100 nucleotides) can be located in coding sequences are located exclusively on autosomesarrow_forward
- From your knowledge about DNA microarray, answer the following: A- How DNA microarray is created? and why it is referred to as “hybridization technology”? B- Why RT-PCR is important in the sample preparation to perform expression microarray experiment? C- Mention the name and the color of the dyes used in expression microarray? D- If the expression microarray experiment was done with a normal sample and a suspected sample, after reading the color pattern resulted from the experiment it was recorded that “gene A22” is expressed in the suspected sample. The gene A22 is clinically linked to colon cancer. Answer the following: What is the expected color of the spot on the microarray which represents this gene? What is your interpretation of the suspected sample; is it a cancer sample or not and explain why?arrow_forwardLiving modified organism (LMO) is defined as any living organism that possesses a novel combination of genetic material obtained through the use of modern biotechnology. Two LMOs that have obtained approval from FDA to be commercialized are the Hawaiian 'Rainbow' papayas and the AquAdvantage salmons. Discuss the advantages of Hawaiian 'Rainbow' papayas and the AquAdvantage salmons over their respective wild type.arrow_forward4) The government of Iceland has built a database which contains genetic informaiton about individuals using SNP analysis and other methods, which can be used to help diagnose pre-disposition to genetic diseases and other conditions. What are some ethical issues that are raised by compiling such a database?arrow_forward
- Human Heredity: Principles and Issues (MindTap Co...BiologyISBN:9781305251052Author:Michael CummingsPublisher:Cengage Learning